INDV
#1358
Indivior Pharmaceuticals, Inc. - Common Stock
40.2 3 USD
0.00%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
年范围
日变化
+0.05%
每月变动
+4.17%
6个月变化
+19.73%
年变化
+19.73%
前一天收盘价
40.2 1
Open
40.2 3
最低价
40.2 3
High
40.2 3
交易量
139
Financials
- Market Capitalization 4.9 B
- Employee 838
- Founded 2014
- CEO Mark Crossley
- Website www.indivior.com
- Headquarter Delaware, United States
- FIGI BBG01ZTXFLQ6
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
21.88
市销率
3.71
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1142 |  LNTH Lantheus Holdings, Inc. - Common Stock | 102.37 USD | -2.87% | -0.82% | -2.50% | +82.61% | 6.66 B USD | ||
| 1296 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 16.69 USD | -2.85% | -1.65% | +2.39% | +58.20% | 5.32 B USD | ||
| 1772 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.65 USD | +11.88% | -2.92% | -66.71% | -61.03% | 2.79 B USD | ||
| 1792 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 46.66 USD | -1.46% | -2.49% | +5.83% | -13.59% | 2.71 B USD |